NCT04777942View on ClinicalTrials.gov

Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA)

NARecruitingINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

February 20, 2021

Primary Completion Date

December 30, 2023

Study Completion Date

December 30, 2026

Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE

neo-TACE-HAIC+Surgery

transartery chemoembolization with lipiodol and EADM, FOLFOX (Oxa 85mg/m2 2h+CF 400mg/m2 2h +5FU 400mg/m2 10min+5FU 1200mg/m2 23h)-based artery infusion chemotherapy, followed by hepatic resection

PROCEDURE

Surgery alone

hepatic resection remove the liver tumors

Trial Locations (1)

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER